期刊文献+

氢溴酸沃替西汀片溶出度测定方法学研究

Study on dissolution determination of Vortioxetine Hydrobromide Tablets
原文传递
导出
摘要 目的建立氢溴酸沃替西汀片的体外溶出度测定方法,分析体外释放行为。方法建立高效液相色谱法测定氢溴酸沃替西汀片溶出度的方法,并考察方法的专属性、线性、精密度、准确性及滤膜干扰。Waters Symmetry C18色谱柱(250mm×4.6 mm,5μm),以水/三氟乙酸混合溶液(1 000∶0.5)为流动相A,甲醇-乙腈-水-三氟乙酸混合溶液(600∶350∶50∶0.35)为流动相B,流动相A与流动相B比例为45∶55,体积流量1.0 mL/min,检测波长为254 nm,柱温40℃。结果在上述色谱条件下,氢溴酸沃替西汀与其同分异构体分离良好。试验专属性、线性、精密度、准确性良好,所使用滤膜对结果测定无干扰。结论该方法准确、可靠、耐用性好,可为氢溴酸沃替西汀片的质量控制提供参考依据。 Objective To establish a method for determining the dissolution of Vortioxetine hydrobromide tablets and analyze the dissolution behavior in vitro. Methods To establish HPLC determination method for the dissolution of Vortioxetine hydrobromide tablets and verify the specificity, linearity, precision, accuracy, membrane filter interference. Chromatographic separation was achieved on an Octa Decyl Silyl column(Waters Symmetry■ C18, 150 mm × 4.6 mm ID, 5 μm particle); Mobile phase A: water –trifluoroacetic acid(1 000 : 0.5), mobile phase B: methyl alcohol-acetonitrile-water-trifluoroacetic acid(600:350:50:0.35). The flow rate was 1.0 mL/min and the detection wavelength was 254 nm, column temperature was 40℃. Results Under the chromatographic conditions, the resolution of Vortioxetine hydrobromide and structural isomer was great, the specificity, linearity,precision, accuracy of the method was good, the membrane filter didn’t affect the results, Conclusion The method is accurate,reliable and durable, and can be used in the quality control of Vortioxetine hydrobromide tablets.
作者 华东东 米楠 臧可昕 阎卉 房思萌 HUA Dongdong;MI Nan;ZANG Kexin;YAN Hui;FANG Simeng(Tianjin Pharmaceutical Research Institute Co.,LTD, Tianjin 300193, China)
机构地区 天津药物研究院
出处 《药物评价研究》 CAS 2018年第11期2011-2014,共4页 Drug Evaluation Research
关键词 氢溴酸沃替西汀片 溶出度 高效液相色谱法 Vortioxetine Hydrobromide Tablets dissolution HPLC
  • 相关文献

参考文献2

二级参考文献24

  • 1何艺兵,赵元慧,王连生,安凤春,莫汉宏,杨克武,刘晔,余刚,徐晓白.有机化合物正辛醇/水分配系数的测定[J].环境化学,1994,13(3):195-197. 被引量:23
  • 2GIBB A, DEEKS ED. Vortioxetine: first global approval[ J]. Drugs, 2014,74(1) :135 - 145. 被引量:1
  • 3CITROME L. Vortioxetine for major depressive disorder: a sys- tematic review of the efficacyand safety profile for this newly ap- proved antidepressant-what is the numberneeded to treat, number needed to harm and likelihood to be helped or harmed? [ J]. Int J Clin Pract, 2014,68( 1 ) :60 -82. 被引量:1
  • 4BANG-ANDERSEN B, RUHLAND T, JORGENSEN M, et al. Discovery ofl -[ 2-( 2,4-dimethylphenylsul-fanyl ) phenyl ] pipera- zine( Lu AA21004) : a novel muhimodal compound for the treat- ment of majordepressive disorder [ J ]. J Med Chem , 2011,54 (9) :3206 - 3221. 被引量:1
  • 5MORK A, MONTEZINHO LP, MILLER S, et al. Vortioxetine (LuAA21004), a novel muhimodal antidepressant, enhances memoryin rats [ J ]. Pharmacol Biochem Behav, 2013,105 ( Suppl C) : S41 - S50. 被引量:1
  • 6SANCHEZ C, PEHRSON AL, BETRY C, et al. Vortioxetine (LUaa21004), an investigational multimodal antidepressant: differ-entiation from currently used antidepressants in preclinical rodentmodels [ abstract ] [ J ]. Biol Psychiatry, 2013,73 ( 9 Suppl 1) : S106 - S107. 被引量:1
  • 7HADDJERI N, ETIEVANT A, PEHRSON A, et al. Effects of the muhi-modal antidepressant Lu AA21004 on rat synaptic and cellularhippocampal plasticity and memory recognition [ abstract no. P. 2. h. 002 ] [ J ]. Eur Neuropsychopharmacol, 2012,22 ( Suppl 2) :S303. 被引量:1
  • 8THEUNISSEN EL, STREET D, HOJER AM, et al. A random- ized trial onthe acute and steady-state effects of a new antidepres- sant, vorti-oxetine (Lu AA21004), on actual driving and cogni- tion [ J ]. Clin Pharmacol Ther, 2013,93 ( 6 ) :493 - 501. 被引量:1
  • 9AREBERG J, SOGAARD B, HOJER AM. The clinical pharma- cokineticsof Lu AA21004 and its major metabolite in healthy young volunteers [ J ]. Basic Clin Pharmacol Toxicol, 2012,111 (3) :198 -205. 被引量:1
  • 10BOULENGER JP, LOFT H, OLSEN CK. Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 rag/day: a randomized, double-blind, placebo-controlled, duloxetine-refereneed study in the acute treatment of adult patients with major depressive disor- der[ J]. Int J Clin Psychopharmacol,2014,29(3 ) :138 - 149. 被引量:1

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部